The protein tyrosine kinase inhibitor, Genistein, delays intervertebral disc degeneration in rats by inhibiting the p38 pathway-mediated inflammatory response
Figure 2.IL-1β treatment reduces NPC viability. (A) Viability of NPCs treated with IL-1β. *p<0.05 (B) Viability of NPCs treated with IL-1β and Genistein. *p<0.05.